-
Thomson Medical (SGX:A50) narrowed net loss to S$10.2m (-20.6% y-o-y) in 1HFY26 due to lower net finance costs and steady operating performance, even as the group continues to make heavy investments in specialist services, clinical talent and digital initiatives across its key markets.
Prioritising topline growth to increase market share
- - Read this at SGinvestors.io -
-
While patient volumes in Vietnam increased during the period, this was partially offset by an unfavourable FX impact arising from the weak Vietnamese Dong.
Expanding multi-disciplinary services in SG & MY
- - Read this at SGinvestors.io -
-
In Malaysia, Thomson Hospital Kota Damansara has broaden its specialties, including the Oncology Centre, while Thomson Fertility has been rebranded as a leading centre in reproductive medicine. It will also enhance partnerships with payors and corporates with the planned 500-bed Thomson Hospital Iskandariah in Johor serving both local and cross-border patients, especially with completion of the RTS Link by end-2026.
Vietnam’s long-term growth story intact
- Read more at SGinvestors.io.
Above is an excerpt from a report by Maybank Research.
Clients of Maybank Securities may be the first to access the full PDF report @ https://www.maybanktrade.com.sg/.
Eric Ong Maybank Research | https://www.maybanktrade.com.sg/ 2026-02-12
Previous report by Maybank:
2025-02-13 Thomson Medical - Facing Near-term Challenges, Downgrade To HOLD.
Price targets by other brokers at Thomson Medical Target Prices.
Listing of research reports at Thomson Medical Analyst Reports.
Relevant links:
Thomson Medical Share Price History,
Thomson Medical Announcements,
Thomson Medical Dividend Payout Dates & Corporate Actions,
Thomson Medical News
